financetom
Business
financetom
/
Business
/
Imperial Oil Q3 Earnings, Revenue Decrease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Imperial Oil Q3 Earnings, Revenue Decrease
Nov 4, 2024 12:05 PM

08:26 AM EDT, 11/01/2024 (MT Newswires) -- Imperial Oil ( IMO ) reported Q3 earnings Friday of 2.33 Canadian dollars ($1.67) per diluted share, down from CA$2.76 a year earlier.

Analysts polled by Capital IQ expected CA$2.07.

Revenue for the quarter ended Sept. 30 was CA$13.26 billion, down from CA$13.92 billion a year earlier.

A single analyst surveyed by Capital IQ expected CA$17.52 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Dine Brands Stock Today?
What's Going On With Dine Brands Stock Today?
Aug 6, 2025
Dine Brands Global, Inc ( DIN ). shares are trading lower on Wednesday after the company reported second-quarter adjusted earnings per share of $1.17, missing the analyst consensus estimate of $1.44. Quarterly sales of $230.784 million outpaced the Street view of $223.458 million. Total revenues increased from $206.3 million in the year-ago period. Applebee’s year-over-year domestic comparable same-restaurant sales increased...
Arch Biopartners Doses First Patient in Phase II Trial of LSALT Peptide
Arch Biopartners Doses First Patient in Phase II Trial of LSALT Peptide
Aug 6, 2025
01:18 PM EDT, 08/06/2025 (MT Newswires) -- Arch Biopartners ( ACHFF ) on Wednesday said it successfully dosed the first patient for its LSALT Peptide Phase II trial.. The dosing of the volunteer patient took place over five days as part of the company's Phase II trial evaluating LSALT peptide for the prevention and treatment of cardiac surgery acute kidney...
FTC seeks to block Edwards Lifesciences' acquisition of JenaValve
FTC seeks to block Edwards Lifesciences' acquisition of JenaValve
Aug 6, 2025
Aug 6 (Reuters) - The U.S. Federal Trade Commission sued to block Edwards Lifesciences Corp's ( EW ) acquisition of JenaValve Technology Inc, saying in a lawsuit filed in Washington on Wednesday the merger would decrease competition in the market for a device meant to treat a potentially fatal heart condition. ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved